ALT-946

inhibitor of advanced glycation, improves severe nephropathy in the diabetic transgenic (mREN-2)27 rat

Also Known As:

N-(2-acetamidoethyl)hydrazinecarboximidamide

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Diabetic Nephropathies (Diabetic Nephropathy) 01/01/2001 - "Therefore, ALT-946 should be considered as a treatment for preventing or retarding diabetic nephropathy." 01/01/2001 - "ALT-946, an inhibitor of advanced glycation with a minimal inhibitory effect on nitric oxide synthase, was compared with aminoguanidine in experimental diabetic nephropathy. "

1.	Nitric Oxide Synthase (NO Synthase)
2.	pimagedine (aminoguanidine)